ID: ALA3590203

Max Phase: Preclinical

Molecular Formula: C15H14N2

Molecular Weight: 222.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1cccc(-c2ccccc2CCN)c1

Standard InChI:  InChI=1S/C15H14N2/c16-9-8-13-5-1-2-7-15(13)14-6-3-4-12(10-14)11-17/h1-7,10H,8-9,16H2

Standard InChI Key:  ZJOYJTZKSVHYQN-UHFFFAOYSA-N

Associated Targets(Human)

Alpha-2c adrenergic receptor 4876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 222.29Molecular Weight (Monoisotopic): 222.1157AlogP: 2.73#Rotatable Bonds: 3
Polar Surface Area: 49.81Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.75CX LogP: 2.89CX LogD: 0.62
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.87Np Likeness Score: -0.58

References

1. Szőllősi E, Bobok A, Kiss L, Vass M, Kurkó D, Kolok S, Visegrády A, Keserű GM..  (2015)  Cell-based and virtual fragment screening for adrenergic α2C receptor agonists.,  23  (14): [PMID:25648685] [10.1016/j.bmc.2015.01.013]

Source